Mechanical Thrombectomy for Stroke
Trial Summary
What is the purpose of this trial?
This trial is testing a device called the Penumbra System with Thunderbolt, which removes blood clots from the brain. It targets patients who have had a stroke due to a large vessel blockage and are eligible for clot removal procedures. The device works like a vacuum to clear the blockage and restore blood flow. The Penumbra System has been previously reported to be effective and safe in treating acute stroke caused by large intracranial vessel occlusion.
Research Team
Donald Frei, M.D.
Principal Investigator
HCA HealthONE, LLC (Swedish Medical Center)
David Fiorella, M.D.
Principal Investigator
The Research Foundation for The State University of New York (Stony Brook University)
Eligibility Criteria
This trial is for adults aged 18-80 with acute ischemic stroke due to a blockage in major brain arteries, who can receive treatment within 8 hours of symptom onset. They should have been relatively healthy before the stroke (mRS score 0-2). Pregnant individuals, those with life expectancy under 90 days, or current participation in other drug/device trials are excluded.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Penumbra System with Thunderbolt (Mechanical Thrombectomy Device)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Penumbra Inc.
Lead Sponsor